Study Outlines Rare Case of PWS Patient with Ear Canal and Bone Infection
A new study described a rare case of a young man with Prader-Willi syndrome (PWS) with an invasive infection of the ear canal and ... Read more
Updates
-
-
Report Details Use of Denosumab to Treat Osteoporosis in PWS Patient
A case report suggested that treatment with denosumab (commercial names: Prolia, Xgeva) could be effective for patients with Prader-Willi syndrome (PWS), osteoporosis, and a history of ... Read more -
UConn, Foundation for Prader-Willi Research Create Stem Cell Biobank
UConn Health and the Foundation for Prader-Willi Research (FPWR) announced the creation of a centralized biobank to provide researchers worldwide with high-quality, validated stem ... Read more -
New Blood Test May Help Diagnose Prader-Willi Syndrome, Other Complex Disorders
A new blood test called EpiSign may help identify complex and hard-to-diagnose genomic imprinting disorders such as Prader-Willi syndrome (PWS). EpiSign, available in two versions, can diagnose 19 ... Read more -
Cactus Extract Reduces Appetite in PWS Mouse Model, Study Reports
Treatment with an Indian cactus extract reduces appetite in a mouse model of Prader-Willi syndrome (PWS) by interfering with a serotonin receptor in the animal’s ... Read more
-
Ghrelin Receptor Agonist May Improve Survival of Infants with PWS, Mouse Study Suggests
A compound that could mimic ghrelin hormone activity and trigger its receptor signals could ... -
Millendo Starts Phase 2b/3 Study Evaluating Livoletide as PWS Treatment
Millendo Therapeutics has launched a Phase 2b/3 clinical trial investigating the safety and efficacy ... -
Board Recommends Continuation of Phase 3 Trial of Soleno’s DCCR Treatment for PWS
The Data Safety Monitoring Board recommended the continuation of Soleno Therapeutics’ Phase 3 clinical ... -
Brexit Could Have Real Effects for UK Rare Disease Patients, Experts Warn
Madeline Collin, a 24-year-old activist with Gaucher disease, worries that patients like her will ... -
ConSynance Therapeutics Will Participate in Prader-Willi Trial Consortium
ConSynance Therapeutics, a biotechnology company that has developed two new candidate medicines for Prader-Willi ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Lean Muscle Mass Factors Strongly in Bone Health, Study Using Prader Willi Patients as Model Finds
News
Lean muscle mass is a strong predictor of bone mineral density, or bone health, research that used Prader-Willi syndrome (PWS) as a genetic model to determine which factors influence such density reports. In fact, lean mass was found to ... Read more